Radionuclide-based nanotechnologies in brain tumors: an updated overview
- 16 June 2025
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Imaging
- Vol. 13 (6) , 565-576
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Development of novel radiolabeled antibody-conjugated graphene quantum dots for targeted in vivo breast cancer imaging and biodistribution studiesArabian Journal of Chemistry, 2024
- Neutron-activated, plasmonically excitable Fe-Pt-Yb2O3 nanoparticles delivering anti-cancer radiation against human glioblastoma cellsiScience, 2023
- Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide, 177LuMolecular Pharmaceutics, 2022
- Heparin‐Derived Theranostic Nanoprobes Overcome the Blood–Brain Barrier and Target Glioma in Murine ModelAdvanced Therapeutics, 2022
- One-step synthesis of high-density peptide-conjugated gold nanoparticles with antimicrobial efficacy in a systemic infection modelBiomaterials, 2016
- Indium-111 labeled gold nanoparticles for in-vivo molecular targetingBiomaterials, 2014
- Metallofullerene-Nanoplatform-Delivered Interstitial Brachytherapy Improved Survival in a Murine Model of Glioblastoma MultiformeBioconjugate Chemistry, 2012
- Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with 188Re-lipid nanocapsulesBiomaterials, 2011
- PET imaging of brain cancer with positron emitter-labeled liposomesInternational Journal of Pharmaceutics, 2011
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000